Jade Biosciences Inc. (Nasdaq: JBIO), a biotechnology company focused on therapies for autoimmune diseases, announced its participation in several upcoming industry conferences. The company will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026, at 1:20 p.m. ET (Track 3). It will also take part in the TD Cowen 46th Annual Health Care Conference with a presentation and fireside chat on March 2, 2026, at 10:30 a.m. ET. Additionally, Jade will participate in a fireside chat at the Leerink Global Healthcare Conference on March 11, 2026, at 8:40 a.m. ET, and will host one-on-one investor meetings at the Jefferies Biotech on the Beach Summit from March 10-11, 2026. A live webcast of the presentations will be available on the Events & Presentations page of the Jade Biosciences website, with archived replays accessible for 90 days following each event.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jade Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9652017-en) on February 11, 2026, and is solely responsible for the information contained therein.